Stemedica Cell Technologies, Inc.
- Home
- Companies
- Stemedica Cell Technologies, Inc.
- Services
- Research and Development Services
Research and Development Services
Stemedica has licensed the exclusive, global distribution rights for the ischemic tolerant mesenchymal stem cell (itMSC) and ischemic tolerant neural stem cell (itNSC) products to Life Technologies for research purposes only. In 2014, Life Technologies was acquired by ThermoFisher Scientific. ThermoFisher Scientific now markets the itMSC and itNSC products under its own private label: StemPro® Neural Stem Cells and StemPro® Mesenchymal Stem Cells. All cells sold to ThermoFisher Scientific by Stemedica are produced under cGMP manufacturing standards at Stemedica’s California-licensed facility and are restricted only for pre-clinical purposes.